Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Recommended Ephedra/Guarana Doses Show Harm in Haller Study

This article was originally published in The Tan Sheet

Executive Summary

Recommended doses of ephedra/guarana combinations resulted in "persistent increases" in heart rate and blood pressure as well as "unfavorable actions" on glucose and potassium homeostasis in a small clinical study published in the June Clinical Pharmacology & Therapeutics.

You may also be interested in...



Multi-Ingredient Caffeine Products Easily Top Adverse Event List, Study Finds

The vast majority of adverse events that can be attributed with near certainty to a supplement involve weight-loss or energy-enhancing products, a study conducted by Christine Haller, M.D., finds

Multi-Ingredient Caffeine Products Easily Top Adverse Event List, Study Finds

The vast majority of adverse events that can be attributed with near certainty to a supplement involve weight-loss or energy-enhancing products, a study conducted by Christine Haller, M.D., finds

Multi-Ingredient Caffeine Products Easily Top Adverse Event List, Study Finds

The vast majority of adverse events that can be attributed with near certainty to a supplement involve weight-loss or energy-enhancing products, a study conducted by Christine Haller, M.D., finds

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098338

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel